Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Transaction in Own Shares

8 Sep 2021 07:00

RNS Number : 0370L
Impellam Group plc
08 September 2021
 

8 September 2021

Impellam Group plc

("Impellam" or the "Company")

Transaction in Own Shares

Impellam Group PLC, the 2nd largest staffing business in the UK and 6th largest MSP worldwide, announces that it has made the following purchases of ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") to be cancelled pursuant to the Share Purchase Plan announced on 2 July 2021.

Date of purchase

7 September 2021

Number of Ordinary Shares purchased (aggregated volume):

1,500

Highest Price paid per Ordinary Share (£):

3.43

Lowest Price paid per Ordinary Share (£):

3.43

Volume Weighted Average Price paid per Ordinary Share (£):

3.43

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Following cancellation of the Ordinary Shares purchased, the number of Ordinary Shares in issue and admitted to trading on AIM will be reduced to 45,421,875. This figure of 45,421,875 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Share Purchase Plan.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord Genuity Limited on behalf of Impellam.

Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

1,500

343.00

11:36:34

London Stock Exchange

 

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is a leading Global Talent Acquisition and Managed Workforce Solutions provider supported by talent-focused specialist staffing brands with deep heritages, vertical sector expertise and loyal candidate networks.

Clients across the world trust us to deliver Managed Services and talent-focused Specialist Staffing in the UK, North America, Australasia, the Middle East and Europe. Working with them are 2,500 Impellam people, bringing a wealth of expertise through our 14 market-leading brands across 76 locations. Every year, we connect carefully chosen candidates with good work at all levels. They include technology and digital specialists, scientists, clinical experts, engineers, nurses, doctors, lawyers, teachers, receptionists, drivers, chefs, administrators, warehouse and call centre operatives.

Underpinning everything we do is our Virtuoso strategy which recognises it is our people who make the difference. Virtuosos make and deliver on promises and grow with their customers through sector, service or international expansion which ensures there is never a need for a customer or candidate to leave Impellam. Impellam is the seventh1 largest Global Talent Acquisition and Managed Workforce Solutions provider in the world.

For more information about Impellam Group please visit: www.impellam.com

1 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2019 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSWFMWEFSELU
Date   Source Headline
22nd Dec 201710:12 amRNSDirector/PDMR Shareholding
21st Dec 20177:00 amRNSTransaction in Own Shares
18th Dec 20177:00 amRNSShare Purchase Plan
15th Nov 20173:38 pmRNSTrading Statement
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20174:51 pmRNSDirectorate Change
27th Jul 20177:00 amRNSHalf-year Report
28th Jun 201710:49 amRNSResult of AGM
28th Apr 20172:12 pmRNSDirector/PDMR Shareholding
16th Mar 20175:09 pmRNSAnnual Financial Report & Dividend Record Date
9th Mar 20177:00 amRNSPreliminary Results - Unaudited
15th Dec 20167:00 amRNSTrading Update
28th Jul 20167:00 amRNSHalf-year Report
29th Jun 20169:31 amRNSResult of AGM
5th May 20167:00 amRNSQ1 Trading Update
7th Apr 201611:16 amRNSHolding(s) in Company
5th Apr 20163:21 pmRNSIssue of Equity
30th Mar 20162:11 pmRNSAnnual Financial Report
9th Mar 20167:00 amRNSDividend Record Date
3rd Mar 20167:00 amRNSPreliminary Results - Unaudited
12th Jan 20168:19 amRNSTrading update and joint broker - replacement
12th Jan 20167:00 amRNSTrading update and appointment of joint broker
14th Dec 201512:15 pmRNSDirector/PDMR Shareholding
11th Dec 20158:01 amRNSTotal Voting Rights
8th Dec 20157:00 amRNSAcquisition and Trading Update
16th Nov 201511:35 amRNSResult of General Meeting
30th Oct 20157:00 amRNSPosting of Circular and Notice of General Meeting
27th Oct 20155:25 pmRNSProposed change in nature of Dividend
2nd Sep 20157:00 amRNSGrant of Options
30th Jul 20157:00 amRNSHalf Yearly Report
13th Jul 20159:00 amRNSPosting of circular
30th Jun 201510:04 amRNSResult of AGM
4th Jun 20157:00 amRNSNotice of AGM and change to dividend timetable
17th Mar 20157:00 amRNSDirector/PDMR Shareholding
9th Mar 20154:35 pmRNSIssue of Equity & Director's Shareholding
6th Mar 20159:00 amRNSAnnual Financial Report
3rd Mar 20157:00 amRNSPreliminary Results - Unaudited
16th Jan 20157:00 amRNSPre-Close Trading Update
12th Jan 20157:00 amRNSDirectorate Change
16th Dec 201410:30 amRNSDirectorate Change
13th Nov 20147:30 amRNSHolding(s) in Company
10th Nov 20141:03 pmRNSCompletion of Acquisition and Directorate Change
7th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20148:00 amRNSDirectors' Dealings
4th Nov 20147:10 amRNSPlacing to raise £15 million
4th Nov 20147:00 amRNSAcquisition of Lorien
30th Jul 20147:00 amRNSHalf Yearly Report
18th Jun 20143:44 pmRNSResult of AGM
15th May 20144:00 pmRNSDeath of a Director
7th May 20147:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.